Michael J Lazarus MD
Insider
First SEC filing: Jan. 9, 2006 · Latest: Jan. 9, 2006
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2006 | NVAX | A | 15,000 | $4.60 | $69,000 | 15,000 Direct | · | Acquired | -88.6% (price as of 2026-10-02) |
| Dec. 15, 2005 | NVAX | M | 10,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 15, 2005 | NVAX | S | 10,000 | $4.40 | $44,000 | 11,927 Direct | -45.61% | Disposed | -88.1% (price as of 2026-10-02) |
| Dec. 15, 2005 | NVAX | M | 10,000 | $3.75 | $37,500 | 21,927 Direct | +83.84% | Acquired | -86.1% (price as of 2026-10-02) |
| May 4, 2005 | NVAX | A | 15,000 | $1.48 | $22,200 | 11,927 Direct | · | Acquired | -64.7% (price as of 2026-10-02) |
| March 9, 2004 | NVAX | A | 20,000 | · | · | 117,500 Direct | +20.51% | Acquired | (price as of 2026-10-02) |
| Jan. 23, 2003 | NVAX | P | 1,445 | $3.17 | $4,581 | 11,927 Direct | +13.79% | Acquired | -83.5% (price as of 2026-10-02) |
| Aug. 22, 2001 | NVAX | P | 482 | $13.55 | $6,531 | 11,927 Direct | +4.21% | Acquired | -96.1% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 17, 2006 | NVAX | Option | Common | $4.60 | Feb. 17, 2016 | 15,000 | Acquired |
| Dec. 15, 2005 | NVAX | Stock Option Right-to-Buy | Common | $3.75 | Dec. 29, 2005 | 10,000 | Disposed |
| May 4, 2005 | NVAX | Option (1) | Common | $1.48 | May 4, 2015 | 15,000 | Acquired |
| March 9, 2004 | NVAX | Right-To-Buy | Common | $5.95 | March 9, 2014 | 20,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).